BRD4 and colorectal carcinoma: One of the resistance mechanisms to BET inhibitors is paracrine IL6/IL8-JAK2 signaling in CRC, which induces the phosphorylation of BRD4 at tyrosine 97/98, increasing the binding capacity of BRD4 to chromatin but reducing that to BET inhibitors.